Every round on record, with the sources behind each and the investors on them.
An AI Native biopharmaceutical company
3 sources · checked 1 time, last 1h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The second source’s headline says “$100M Series A,” but its article text and the other sources state only that cumulative Series A funding exceeds $100 million; therefore no amount is assigned. Investor translations also differ, including Fortune Capital versus Dacheng Wealth Capital.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A Series A+ | more than $100M financing total | 2026-10-28 | China Life, China Life Private Equity Investment Company | 3 outlets. #52 in Trending |
3 sources · checked 1 time, last 1h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 3 sources
The second source’s headline says “$100M Series A,” but its article text and the other sources state only that cumulative Series A funding exceeds $100 million; therefore no amount is assigned. Investor translations also differ, including Fortune Capital versus Dacheng Wealth Capital. [ BUILT WITH ]·[ SEARCH ]found on a watched publisher·[ SCRAPE ]3 pages read: google.com, elsewhere.news, en.tmtpost.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 3 sources·[ BRANDING ]logo and colour from the homepage | ||||